Skip to main content
Apt Medical Inc. logo

Apt Medical Inc. — Investor Relations & Filings

Ticker · 688617 ISIN · CNE100004C45 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 661 across all filing types
Latest filing 2025-07-07 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 688617

About Apt Medical Inc.

https://www.aptmed.com/

Apt Medical Inc. is a specialized developer and manufacturer of advanced medical devices for minimally invasive vascular interventions. The company focuses on the fields of electrophysiology, interventional cardiology, and peripheral vascular procedures. Its product portfolio includes diagnostic and ablation catheters, steerable sheaths, guide wires, microcatheters, and balloon catheters designed for complex cardiovascular treatments. Apt Medical emphasizes research and development to provide high-precision tools for clinicians, aiming to improve procedural outcomes in the treatment of cardiac arrhythmias and vascular diseases. The company serves a global market, providing integrated solutions for interventional procedures through a commitment to technological innovation and quality manufacturing standards.

Recent filings

Filing Released Lang Actions
北京市嘉源律师事务所关于深圳惠泰医疗器械股份有限公司2021年限制性股票激励计划授予价格、授予及归属数量调整相关事项的法律意见书
Regulatory Filings
2025-07-07 Chinese
关于变更注册资本暨修订《公司章程》的公告
Share Issue/Capital Change Classification · 95% confidence The document is an official announcement from Shenzhen Huitai Medical Device Co., Ltd. regarding changes in registered capital and amendments to the company's articles of association. It details the increase in registered capital due to stock incentive plans and capital reserve conversion, and the corresponding amendments to the company's charter. The document includes references to board and shareholder meetings approving these changes and states that the revised articles will be filed with the relevant authorities. The content is focused on corporate governance changes related to capital structure and company bylaws, not a full financial report or earnings release. It is not a report publication announcement since it contains substantive information about the capital change and charter amendments. This fits the category of Share Issue/Capital Change (SHA) as it involves changes in registered capital and share structure.
2025-07-07 Chinese
关于调整2021年限制性股票激励计划授予价格、授予及归属数量的公告
Capital/Financing Update Classification · 95% confidence The document is an official announcement from Shenzhen Huitai Medical Device Co., Ltd. regarding adjustments to the 2021 restricted stock incentive plan's grant price, grant quantity, and vesting quantity. It details board and committee meetings, approvals, legal opinions, and specific adjustments to stock incentive terms. The content focuses on changes to a stock incentive plan, including legal compliance and procedural disclosures. It is not a full financial report, earnings release, or management discussion. It is also not a proxy solicitation or voting result announcement. The document is a formal announcement about changes in the company's stock incentive plan, which falls under capital/financing updates related to equity incentives. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length (5866 characters) and detailed content confirm it is not a brief announcement or a report publication announcement but a substantive update on financing-related matters.
2025-07-07 Chinese
湖南依微迪医疗器械有限公司审计报告及财务报表（2025年1-3月）
Regulatory Filings
2025-07-07 Chinese
2024年年度权益分派实施公告
Notice of Dividend Amount Classification · 95% confidence The document is titled as an "Annual Equity Distribution Implementation Announcement" for the year 2024 by Shenzhen Huitai Medical Devices Co., Ltd. It details the dividend distribution plan, including cash dividends per share, stock dividend (capital reserve to share capital conversion), relevant dates for record, ex-dividend, and payment, as well as tax treatment for different shareholder categories. It also mentions the approval of the plan at the 2024 Annual General Meeting held on May 13, 2025. The document is 3237 characters long, which is relatively short and primarily serves as an announcement of the dividend distribution details rather than a full financial report. It does not contain comprehensive financial statements or management discussion and analysis. Therefore, it fits best into the category of "Notice of Dividend Amount" (DIV), which covers announcements of dividend amounts, payment dates, and related shareholder information.
2025-06-12 Chinese
中信证券股份有限公司关于深圳惠泰医疗器械股份有限公司2024年持续督导工作现场检查报告
Audit Report / Information Classification · 95% confidence The document is titled as a "2024年持续督导工作现场检查报告" (2024 Continuous Supervision On-site Inspection Report) issued by the sponsor (中信证券股份有限公司) regarding 深圳惠泰医疗器械股份有限公司. It details the sponsor's on-site inspection covering governance, internal controls, information disclosure, independence, related party transactions, use of raised funds, and operational status during the continuous supervision period in 2024. The document is a detailed report of the sponsor's supervisory activities and findings, not an annual or interim financial report, nor an announcement or certification. It is a standalone audit/supervisory report related to regulatory compliance and internal controls, fitting the category of Audit Report / Information (AR). The document length is under 5,000 characters but contains substantive content and is not merely an announcement or certification, so it is not RPA or RNS. Therefore, the best classification is AR with high confidence. FY 2024
2025-06-06 Chinese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.